ArticleBlood2014
Secreting von Willebrand factor in a Gα-SNAP.
Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this issue of Blood, Rusu et al use a state-of-the-art combination of pharmacological, genetic, and molecular techniques to dissect a mechanism for von Willebrand factor (vWF) secretion from endothelial cells mediated via Gaq/11 and Ga12 that can be triggered in basal or stimulated conditions. Indeed, although the storage of vWF in Weibel-Palade bodies (WPBs) of endothelial cells has been known for decades, the molecular mechanisms governing WPB docking with plasma membrane and vWF secretion remains undefined. One of the reasons this is still a very active area of investigation is that understanding the mechanism behind WPB docking is crucial for understanding potential pharmacological targets for pathological conditions associated with platelet aggregation/thrombi (e.g., stroke), where vWF levels directly correlate with severity of disease progress. The work by Rusu et al opens up a new area of investigation into G-protein-coupled receptors as triggers for WPB fusion at the plasma membrane and for vWF secretion.
Indexed as
Identifiers
24434997What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.